Miragen Therapeutics Inc (MGEN) - Financial and Strategic SWOT Analysis Review

  • ID: 4278624
  • SWOT Analysis
  • 48 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Bristol-Myers Squibb Co
  • Celgene Corp
  • Merck & Co Inc
  • MORE
Miragen Therapeutics Inc (MGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the Author to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Miragen Therapeutics, Inc. (Miragen) is a clinical stage biopharmaceutical company. It discovers and develops RNA-targeted therapeutics with a focus on microRNAs and their role in diseases. The company is developing its pipeline products for the treatment of Cutaneous T-Cell Lymphoma (CTCL), Adult T-Cell Lymphoma/Leukemia, Diffuse Large-B Cell Lymphoma, Chronic Lymphocytic Leukemia, ALS, Heart Failure, Incisional Complications, Cutaneous Fibrosis, Idiopathic Pulminary Fibrosis and Other Fibrotic Indications. The pipeline development is focused on microRNA platform that regulate gene expression and influences the pathways responsible for many disease processes. Miragen is headquartered in Boulder, Colorado, the US.

Miragen Therapeutics Inc Key Recent Developments

Aug 07,2018: miRagen Therapeutics announces second quarter 2018 financial results
May 09,2018: miRagen Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update
Mar 14,2018: miRagen Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
Jan 05,2018: miRagen Therapeutics Expands Board of Directors With Appointment of Arlene Morris
Nov 08,2017: miRagen Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Bristol-Myers Squibb Co
  • Celgene Corp
  • Merck & Co Inc
  • MORE
Section 1 - About the Company
Miragen Therapeutics Inc - Key Facts
Miragen Therapeutics Inc - Key Employees
Miragen Therapeutics Inc - Key Employee Biographies
Miragen Therapeutics Inc - Major Products and Services
Miragen Therapeutics Inc - History
Miragen Therapeutics Inc - Company Statement
Miragen Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis
Company Overview
Miragen Therapeutics Inc - Business Description
R&D Overview
Miragen Therapeutics Inc - Corporate Strategy
Miragen Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Miragen Therapeutics Inc - Strengths
Miragen Therapeutics Inc - Weaknesses
Miragen Therapeutics Inc - Opportunities
Miragen Therapeutics Inc - Threats
Miragen Therapeutics Inc - Key Competitors

Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances
Miragen Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Miragen Therapeutics Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018
Miragen Therapeutics Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments
Aug 07, 2018: miRagen Therapeutics announces second quarter 2018 financial results
May 09, 2018: miRagen Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update
Mar 14, 2018: miRagen Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
Jan 05, 2018: miRagen Therapeutics Expands Board of Directors With Appointment of Arlene Morris
Nov 08, 2017: miRagen Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update
Aug 11, 2017: miRagen Therapeutics Reports Second Quarter 2017 Financial Results and Provides Corporate Update
May 10, 2017: miRagen Therapeutics Reports First Quarter 2017 Financial Results and Provides Corporate Update
Mar 31, 2017: miRagen Therapeutics Provides Corporate Update

Section 6 – Appendix
Methodology
Ratio Definitions
About
Contact Us
Disclaimer

List of Tables
Miragen Therapeutics Inc, Key Facts
Miragen Therapeutics Inc, Key Employees
Miragen Therapeutics Inc, Key Employee Biographies
Miragen Therapeutics Inc, Major Products and Services
Miragen Therapeutics Inc, History
Miragen Therapeutics Inc, Subsidiaries
Miragen Therapeutics Inc, Key Competitors
Miragen Therapeutics Inc, Ratios based on current share price
Miragen Therapeutics Inc, Annual Ratios
Miragen Therapeutics Inc, Annual Ratios (Cont...1)
Miragen Therapeutics Inc, Interim Ratios
Miragen Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Miragen Therapeutics Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018
Miragen Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Miragen Therapeutics Inc, Performance Chart (2013 - 2017)
Miragen Therapeutics Inc, Ratio Charts
Miragen Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Miragen Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Merck & Co Inc
  • Celgene Corp
  • Bristol-Myers Squibb Co
  • Actelion Pharmaceuticals Ltd
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll